Metabolic & Cardiometabolic
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 LLY | Eli Lilly & Co. | $0.8t | $925.41 | -1.1% | 589.3K |
 AZN | AstraZeneca PLC | $300.7b | $203.91 | +0.2% | 260.8K |
 MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $11.6b | $546.20 | -0.1% | 81.8K |
 PTGX | Protagonist Therapeutics, Inc | $6.4b | $102.41 | -1.3% | 71.5K |
 TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.0b | $52.76 | +0.1% | 1.9M |
 KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $3.5b | $49.62 | +1.6% | 314.3K |
 VKTX | Viking Therapeutics, Inc | $3.5b | $34.88 | +0.2% | 723.2K |
 NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $3.4b | $33.91 | +2.8% | 282.6K |
 TVTX | Travere Therapeutics, Inc. Common Stock | $2.6b | $32.67 | +7.3% | 939.7K |
 MLYS | Mineralys Therapeutics, Inc. Common Stock | $1.9b | $27.54 | +2.1% | 276.5K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.4b | $29.38 | +2.3% | 146.5K |
 MBX | MBX Biosciences, Inc. Common Stock | $1.3b | $32.83 | -0.5% | 128.3K |
 SEPN | Septerna, Inc. Common Stock | $1.0b | $25.18 | +0.0% | 36.1K |
 MNKD | Mannkind Corporation | $0.7b | $2.54 | +1.8% | 788.7K |
 BIOA | BioAge Labs, Inc. Common Stock | $0.7b | $17.52 | +0.1% | 64.7K |
 ESPR | Esperion Therapeutics, Inc. | $0.7b | $2.63 | +0.6% | 3.0M |
 LXRX | Lexicon Pharmaceuticals, Inc. | $0.6b | $1.63 | +2.2% | 589.7K |
 GYRE | Gyre Therapeutics, Inc. Common Stock | $0.6b | $7.19 | +1.0% | 11.2K |
 ALT | Altimmune, Inc. Common Stock | $374.7m | $3.44 | +3.1% | 860.7K |
 RZLT | Rezolute, Inc. Common Stock (NV) | $272.7m | $3.23 | +3.4% | 234.3K |
 TENX | Tenax Therapeutics, Inc. | $240.9m | $15.70 | +4.6% | 162.2K |
 SGMT | Sagimet Biosciences Inc. Series A Common Stock | $148.3m | $5.31 | -0.2% | 88.0K |
 VTVT | vTv Therapeutics Inc. Class A Common Stock | $144.5m | $40.70 | -1.1% | 15.6K |
 CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $136.2m | $1.37 | -2.8% | 229.8K |
 ORMP | Oramed Pharmaceuticals Inc. | $130.6m | $3.44 | +0.7% | 15.9K |
 MIST | Milestone Pharmaceuticals Inc. Common Shares | $118.8m | $1.48 | +6.9% | 1.4M |
 BMEA | Biomea Fusion, Inc. Common Stock | $95.4m | $1.52 | -1.0% | 606.2K |
 AARD | Aardvark Therapeutics, Inc. Common Stock | $79.4m | $4.12 | -4.3% | 96.5K |
 VANI | Vivani Medical, Inc. Common Stock (DE) | $79.4m | $1.09 | +1.4% | 63.5K |
 GUTS | Fractyl Health, Inc. Common Stock | $67.7m | $0.44 | -2.8% | 422.6K |
 LPCN | Lipocine Inc. | $55.3m | $2.02 | -1.2% | 1.6M |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $40.6m | $8.38 | +5.1% | 12.5K |
 VERU | Veru Inc. | $34.2m | $2.38 | +3.9% | 39.1K |
 SKYE | Skye Bioscience, Inc. Common Stock | $19.8m | $0.70 | -0.1% | 32.4K |
 CURX | Curanex Pharmaceuticals Inc Common Stock | $13.8m | $0.53 | +7.3% | 84.1K |
 CVKD | Cadrenal Therapeutics, Inc. Common Stock | $9.9m | $4.68 | -0.3% | 5.1K |
 NCEL | NewcelX Ltd. Ordinary Shares | $8.6m | $2.25 | 0.0% | 4.9K |
 GRDX | GridAI Technologies Corp. Common Stock | $6.8m | $2.23 | -6.7% | 10.1K |
 TCRT | Alaunos Therapeutics, Inc. Common Stock | $6.3m | $2.98 | +1.6% | 1.9K |
 MTVA | MetaVia Inc. Common Stock | $6.0m | $1.28 | +2.0% | 44.1K |
 GLMD | Galmed Pharmaceuticals Ltd. | $3.1m | $0.54 | -0.9% | 30.2K |
 ELAB | PMGC Holdings Inc. Common Stock | $1.9m | $4.55 | -20.5% | 3.3M |